Event Abstract

Sulfated hyaluronan affects fibronectin matrix assembly by human bone marrow stromal cells

  • 1 TU Dresden, Institute of Physiological Chemistry, Carl Gustav Carus Faculty of Medicine, Germany
  • 2 Innovent e. V, Biomaterials Department, Germany
  • 3 ETH Zurich, Laboratory of Applied Mechanobiology, Department of Health Science and Technology, Switzerland
  • 4 Tu Dresden, Structural Bioinformatics, Biotec, Germany

Introduction: In the bone marrow niche, human bone marrow stromal cells (hBMSC) are surrounded by extracellular matrix (ECM) containing CaP, collagen I, fibronectin (FN) and sulfated glycosaminoglycans (sGAG). Synthetically sulfated hyaluronan (sHA1) has been shown to support osteogenesis of hBMSC[1] and to inhibit osteoclast formation[2].

Osteoblasts synthesize large amounts of FN and deposit the protein into the bone matrix. FN is secreted as a 440 kDa dimeric glycoprotein with binding domains for cells via integrins and several ECM components like collagen I and heparin. The assembly of FN fibrils is a cell-mediated process and depends on integrin binding[3].

In this study we describe the effects of sHA1 on FN matrix assembly by hBMSC in vitro.

Materials and Methods: The sulfation of native HA was performed with SO3/DMF and resulted in sHA1with a sulfation degree of 1.3 and a molecular weight of 26,600 g/mol[4]. Fluorescence-labelled HA and sHA1 were obtained with Atto565-NH2 using side-on modification[2].

Human BMSC were cultured in DMEM with 10% FCS supplemented with 200 µg HA or sHA1 / ml[1]. For characterization of FN matrix at day 8, immunofluorescence staining was performed[1]. The influence of HA and sHA1 on FN matrix assembly was characterized using FRET-assay[5].

Results and Discussion: Immunofluorescence staining indicated a colocalization of Atto565-sHA1 and FN fibrils (figure 1C) but no colocalization of Atto565-HA and FN (figure 1B). In silico studies supported the electrostatic interaction between sHA1 and heparin binding sites which might affect growth factor binding and FN fibril formation.

Figure 1: Immunofluorescence staining of hBMSC at day 8 (A) and after permanent treatment with Atto565-HA (B) or Atto565-sHA1 (C). FN (green), Nuclei (blue).

It was found that sHA1 affected FN matrix assembly as more and thinner FN fibrils were formed in comparison to untreated control and HA (figure 1). The effect of sHA1 on FN matrix assembly was more detailed characterized by FRET-analysis which confirmed FN-stretching in the presence of sHA1 similar to heparin[5].

Besides its effects on FN assembly, sHA1 induced FN protein and influenced its remodeling by reducing activity of matrix metalloproteinases and increasing the formation of tissue inhibitor of metalloproteinase-3 (TIMP-3)[6],[7].

Conclusion: The present study shows one putative mechanism how sHA1 influences ECM assembly and remodelling. Our findings contribute to clarify the impact of sHA1 on molecular mechanisms in hBMSC.

Deutsche Forschungsgemeinschaft TRR67 (projects B1, A7, Z3)

References:
[1] Hempel et al., Acta Biomaterialia 8: 4064-4072, 2012.
[2] Salbach-Hirsch et al., J. Cell. Biochem. 115: 1101-1111, 2014.
[3] Schwarzbauer and De Simone, Col Spring Harb Perspect Biol, 2011.
[4] Becher et al., Carbohydrate Polymers 90: 608-615, 2012.
[5] Li et al., Biomaterial Science 3: 73-84, 2014.
[6] Kliemt et al., J. Proteome Research 12: 378-389, 2013.
[7] Schmidt et al., Mol Cell Proteomics 2015, accepted.

Keywords: Bone Regeneration, Extracellular Matrix, stem cell, Cell response

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Protein interactions with biomaterials

Citation: Vogel S, Moeller S, Arnoldini S, Samsonov S, Schnabelrauch M, Vogel V and Hempel U (2016). Sulfated hyaluronan affects fibronectin matrix assembly by human bone marrow stromal cells. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01366

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.